These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5013383)

  • 1. Determination of erythromycin in pharmaceutical preparations by direct densitometry after TLC.
    Radecka C; Wilson WL; Hughes DW
    J Pharm Sci; 1972 Mar; 61(3):430-1. PubMed ID: 5013383
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of sodium cromoglycate in pharmaceutical dosage forms using TLC-densitometry.
    Kocić-Pesić V; Radulovic D; Pećanac D; Zivanović L
    Farmaco; 1992 Dec; 47(12):1563-7. PubMed ID: 1294171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct densitometric determination of tetracycline in pharmaceutical preparations.
    Radecka C; Wilson WL
    J Chromatogr; 1971 May; 57(2):297-302. PubMed ID: 5575725
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythromycin series. V. Quantitative analysis of cladinose and methylcladinoside by densitometry of thin-layer chromatograms.
    Lazarevski T; Tamburasev Z; Djokić S
    J Chromatogr; 1977 Feb; 132(2):309-13. PubMed ID: 833239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of erythromycin estolate in pharmaceutical preparations containing tetracycline].
    Macioci F; Fiotek C
    Boll Chim Farm; 1973 Aug; 112(8):543-52. PubMed ID: 4770236
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of sulfametrole in commercial dosage forms (Lidaprim) by TLC densitometry.
    Bertini D; Nuti V
    Farmaco; 1990 Oct; 45(10):1129-36. PubMed ID: 2095156
    [No Abstract]   [Full Text] [Related]  

  • 7. The determination of nikethamide and other compounds in pharmaceutical dosage forms by thin-layer chromatography.
    Carmichael WM
    Analyst; 1971 Oct; 96(147):716-20. PubMed ID: 4331847
    [No Abstract]   [Full Text] [Related]  

  • 8. Stability-indicating TLC-densitometric method for estimation of dexrabeprazole and domperidone in pharmaceutical dosage form.
    Chitlange SS; Mulla AI; Pawbake GR; Wankhede SB
    Prep Biochem Biotechnol; 2010; 40(4):337-46. PubMed ID: 21108137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances in pharmaceutical technology in 1966-1967. II. Drugs and pharmaceutical preparations].
    Chalabala M; Malý J; Burelová A; Starha L; Heliová M; Rak J; Rehula A
    Cesk Farm; 1968 Nov; 17(9):450-61. PubMed ID: 4888356
    [No Abstract]   [Full Text] [Related]  

  • 10. Microencapsulation.
    Luzzi LA
    J Pharm Sci; 1970 Oct; 59(10):1367-76. PubMed ID: 4919443
    [No Abstract]   [Full Text] [Related]  

  • 11. [Suggestions and recommendations for standardization of the systemic "routine" control during the production of the pharmaceutical dosage forms and their manufacturing].
    Bellentani L; Carugati E; Colombo A; Ingraffia P
    Boll Chim Farm; 1971 Mar; 110(3):131-46 contd. PubMed ID: 5561774
    [No Abstract]   [Full Text] [Related]  

  • 12. Thin-layer chromatographic determination of erythromycin and other macrolide antibiotics in livestock products.
    Petz M; Solly R; Lymburn M; Clear MH
    J Assoc Off Anal Chem; 1987; 70(4):691-7. PubMed ID: 3624179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reversed-phase high-performance liquid chromatographic method for the determination and identification of clarithromycin as the drug substance and in various dosage forms.
    Morgan DK; Brown DM; Rotsch TD; Plasz AC
    J Pharm Biomed Anal; 1991; 9(3):261-9. PubMed ID: 1831386
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of erythromycin C in erythromycin finished products and fermentation broths by thin layer chromatography].
    Korchagin VB; Vtorova ZE
    Antibiotiki; 1973 Mar; 18(3):202-5. PubMed ID: 4587460
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of the potassium salt of benzylpenicillin, erythromycin and nystatin in drug forms].
    Guseva LN; Mukhanova LI
    Farmatsiia; 1974; (6):20-5. PubMed ID: 4464114
    [No Abstract]   [Full Text] [Related]  

  • 16. [Component composition and admixtures of related compounds in commercial preparations with an erythromycin base].
    Zak AF; Batuashvili TA
    Antibiotiki; 1977 Nov; 22(11):970-4. PubMed ID: 596843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical heterogeneous system. IV. A kinetic approach to the stability screening of solid dosage forms containing aspirin.
    Maulding HV; Zoglio MA; Pigois FE; Wagner M
    J Pharm Sci; 1969 Nov; 58(11):1359-62. PubMed ID: 5349749
    [No Abstract]   [Full Text] [Related]  

  • 18. Simple thin-layer chromatographic identification method for erythromycin stearate.
    Graham KC; Wilson WL; Vilim A
    J Chromatogr; 1976 Oct; 125(2):447-50. PubMed ID: 977688
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum antibacterial activity after oral suspensions and capsules of triacetyloleandomycin and erythromycin estolate.
    Saslaw S; Carlisle HN
    Appl Microbiol; 1970 Feb; 19(2):370-4. PubMed ID: 5309528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability indicating reversed-phase high-performance liquid chromatographic and thin layer densitometric methods for the determination of ziprasidone in bulk powder and in pharmaceutical formulations.
    El-Sherif ZA; El-Zeany B; El-Houssini OM; Rashed MS; Aboul-Enein HY
    Biomed Chromatogr; 2004 Apr; 18(3):143-9. PubMed ID: 15103698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.